QQQ   303.46 (+1.28%)
AAPL   122.72 (+3.08%)
MSFT   216.21 (+1.00%)
FB   286.55 (+3.46%)
GOOGL   1,795.36 (+2.33%)
AMZN   3,220.08 (+1.64%)
TSLA   584.76 (+3.02%)
NVDA   535.60 (-0.09%)
BABA   264.01 (+0.25%)
CGC   26.65 (-7.47%)
GE   10.15 (-0.29%)
MU   67.08 (+4.67%)
AMD   92.63 (-0.03%)
T   28.87 (+0.42%)
NIO   45.36 (-10.23%)
F   9.24 (+1.76%)
ACB   9.75 (-16.52%)
NFLX   504.58 (+2.83%)
BA   213.01 (+1.09%)
GILD   61.12 (+0.74%)
DIS   149.44 (+0.97%)
QQQ   303.46 (+1.28%)
AAPL   122.72 (+3.08%)
MSFT   216.21 (+1.00%)
FB   286.55 (+3.46%)
GOOGL   1,795.36 (+2.33%)
AMZN   3,220.08 (+1.64%)
TSLA   584.76 (+3.02%)
NVDA   535.60 (-0.09%)
BABA   264.01 (+0.25%)
CGC   26.65 (-7.47%)
GE   10.15 (-0.29%)
MU   67.08 (+4.67%)
AMD   92.63 (-0.03%)
T   28.87 (+0.42%)
NIO   45.36 (-10.23%)
F   9.24 (+1.76%)
ACB   9.75 (-16.52%)
NFLX   504.58 (+2.83%)
BA   213.01 (+1.09%)
GILD   61.12 (+0.74%)
DIS   149.44 (+0.97%)
QQQ   303.46 (+1.28%)
AAPL   122.72 (+3.08%)
MSFT   216.21 (+1.00%)
FB   286.55 (+3.46%)
GOOGL   1,795.36 (+2.33%)
AMZN   3,220.08 (+1.64%)
TSLA   584.76 (+3.02%)
NVDA   535.60 (-0.09%)
BABA   264.01 (+0.25%)
CGC   26.65 (-7.47%)
GE   10.15 (-0.29%)
MU   67.08 (+4.67%)
AMD   92.63 (-0.03%)
T   28.87 (+0.42%)
NIO   45.36 (-10.23%)
F   9.24 (+1.76%)
ACB   9.75 (-16.52%)
NFLX   504.58 (+2.83%)
BA   213.01 (+1.09%)
GILD   61.12 (+0.74%)
DIS   149.44 (+0.97%)
QQQ   303.46 (+1.28%)
AAPL   122.72 (+3.08%)
MSFT   216.21 (+1.00%)
FB   286.55 (+3.46%)
GOOGL   1,795.36 (+2.33%)
AMZN   3,220.08 (+1.64%)
TSLA   584.76 (+3.02%)
NVDA   535.60 (-0.09%)
BABA   264.01 (+0.25%)
CGC   26.65 (-7.47%)
GE   10.15 (-0.29%)
MU   67.08 (+4.67%)
AMD   92.63 (-0.03%)
T   28.87 (+0.42%)
NIO   45.36 (-10.23%)
F   9.24 (+1.76%)
ACB   9.75 (-16.52%)
NFLX   504.58 (+2.83%)
BA   213.01 (+1.09%)
GILD   61.12 (+0.74%)
DIS   149.44 (+0.97%)
Log in
NYSE:CMD

Cantel Medical Stock Forecast, Price & News

$59.75
+0.32 (+0.54 %)
(As of 12/1/2020 12:00 AM ET)
Add
Compare
Today's Range
$59.25
Now: $59.75
$61.78
50-Day Range
$43.92
MA: $52.59
$59.95
52-Week Range
$20.81
Now: $59.75
$79.50
Volume275,997 shs
Average Volume558,188 shs
Market Capitalization$2.52 billion
P/E Ratio145.74
Dividend YieldN/A
Beta1.38
Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratories, food and beverage, and commercial industrial customers, as well as microbiological testing services. The company's Dental segment offers hand and powered dental instruments, instrument reprocessing and sterility assurance products, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.
Cantel Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.3Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.46 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone973-890-7220
Employees3,669

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.02 billion
Cash Flow$3.49 per share
Book Value$17.31 per share

Profitability

Net Income$13.71 million

Miscellaneous

Market Cap$2.52 billion
Next Earnings DateN/A
OptionableOptionable
$59.75
+0.32 (+0.54 %)
(As of 12/1/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CMD News and Ratings via Email

Sign-up to receive the latest news and ratings for CMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cantel Medical (NYSE:CMD) Frequently Asked Questions

How has Cantel Medical's stock been impacted by Coronavirus (COVID-19)?

Cantel Medical's stock was trading at $49.70 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CMD shares have increased by 20.2% and is now trading at $59.75.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Cantel Medical?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cantel Medical in the last year. There are currently 1 sell rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Cantel Medical
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Cantel Medical?

Wall Street analysts have given Cantel Medical a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cantel Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Cantel Medical's earnings last quarter?

Cantel Medical Corp. (NYSE:CMD) announced its quarterly earnings data on Thursday, September, 17th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.08 by $0.16. The business earned $233.37 million during the quarter, compared to analysts' expectations of $233.05 million. Cantel Medical had a return on equity of 9.72% and a net margin of 1.68%.
View Cantel Medical's earnings history
.

How often does Cantel Medical pay dividends? What is the dividend yield for Cantel Medical?

Cantel Medical announced a Semi-Annual dividend on Wednesday, December 18th. Shareholders of record on Friday, January 17th will be paid a dividend of $0.105 per share on Friday, January 31st. The ex-dividend date of this dividend is Thursday, January 16th. This is a boost from Cantel Medical's previous Semi-Annual dividend of $0.10.
View Cantel Medical's dividend history
.

What price target have analysts set for CMD?

4 analysts have issued 1-year target prices for Cantel Medical's shares. Their forecasts range from $51.00 to $70.00. On average, they expect Cantel Medical's share price to reach $62.75 in the next year. This suggests a possible upside of 5.0% from the stock's current price.
View analysts' price targets for Cantel Medical
.

Who are some of Cantel Medical's key competitors?

What other stocks do shareholders of Cantel Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cantel Medical investors own include Gilead Sciences (GILD), JPMorgan Chase & Co. (JPM), Medtronic (MDT), NVIDIA (NVDA), Cisco Systems (CSCO), Netflix (NFLX), Broadcom (AVGO), Alibaba Group (BABA), Bank of America (BAC) and Citigroup (C).

Who are Cantel Medical's key executives?

Cantel Medical's management team includes the following people:
  • Mr. Charles Michael Diker, Chairman & Member of Office of the Chairman (Age 85, Pay $520.45k)
  • Mr. George L. Fotiades, CEO, Vice Chairman & Member of Office of the Chairman (Age 66, Pay $254.42k)
  • Mr. Peter G. Clifford, Pres & COO (Age 50, Pay $852k)
  • Mr. Shaun M. Blakeman, Sr. VP, CFO & Member of Office of the Chairman (Age 42, Pay $205.04k)
  • Mr. Seth M. Yellin, Exec. VP & Chief Growth Officer (Age 46, Pay $635.33k)
  • Mr. Brian R. Capone, Sr. VP, Corp. Controller & Chief Accounting Officer (Age 45)
  • Mr. Michael Drexel, CTO & Sr. VP
  • Mr. Matthew Micowski, VP of Corp. FP&A and Investor Relations
  • Mr. Jeffrey Z. Mann, Sr. VP, Gen. Counsel, Corp. Sec. & Member of Office of the Chairman (Age 48)
  • Ms. Milicent Brooks, Head of Corp. Communications

What is Cantel Medical's stock symbol?

Cantel Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "CMD."

How do I buy shares of Cantel Medical?

Shares of CMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cantel Medical's stock price today?

One share of CMD stock can currently be purchased for approximately $59.75.

How big of a company is Cantel Medical?

Cantel Medical has a market capitalization of $2.52 billion and generates $1.02 billion in revenue each year. The company earns $13.71 million in net income (profit) each year or $1.65 on an earnings per share basis. Cantel Medical employs 3,669 workers across the globe.

What is Cantel Medical's official website?

The official website for Cantel Medical is www.cantelmedical.com.

How can I contact Cantel Medical?

Cantel Medical's mailing address is 150 CLOVE ROAD, LITTLE FALLS NJ, 07424. The company can be reached via phone at 973-890-7220 or via email at [email protected]telmedical.com.

This page was last updated on 12/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.